Stocks
Talphera, Inc.TLPH
NASDAQHealthcareBiotechnology$1.07
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing therapies for acute and chronic pain, with a focus on non-opioid treatments. Its lead candidate, TP-2021, is in Phase 2 trials for postoperative pain, and the company also has a preclinical pipeline targeting other pain indications. Investors track Talphera for its potential to address the opioid crisis through novel mechanisms.
52W Range: $0.69-$1.57
Congressional Interest in Talphera, Inc. (TLPH)
No congressional trades have been disclosed for Talphera, Inc. (TLPH) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading TLPH?
No congressional trades found for this stock.